Articles From: FireEye Awarded 5-Star Rating in CRN's 2014 Partner Program Guide to Crown Holdings Completes Mivisa Acquisition


MILPITAS, Calif., April 1, 2014 (GLOBE NEWSWIRE) -- FireEye, Inc. (Nasdaq:FEYE) , the leader in stopping today's advanced cyber attacks, today announced it has been awarded a 5-Star rating in the CRN 2014 Partner Program Guide.
Sign-up for FireEye Awarded 5-Star Rating in CRN's 2014 Partner Program Guide investment picks
NEW YORK, April 1, 2014 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp.
Sign-up for Tonix Pharmaceuticals Appoints Donald J. Kellerman Senior Vice President, Clinical Development and Regulatory Affairs investment picks
HOUSTON, April 1, 2014 (GLOBE NEWSWIRE) -- Crown Castle International Corp.
Sign-up for Crown Castle Announces Proposed Offering of Senior Notes investment picks
BURLINGTON, Mass., April 2, 2014 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that CEO Michael Clayman, M.D., will present an overview of the company at the 13th Annual Needham Healthcare Conference .
Sign-up for Flexion Therapeutics to Present at the 13th Annual Needham Healthcare Conference investment picks
SHANGHAI, China, April 2, 2014 (GLOBE NEWSWIRE) -- Montage Technology Group Limited ("Montage") (Nasdaq:MONT) , a global fabless provider of analog and mixed-signal semiconductor solutions for the home entertainment and cloud computing markets, today announced the production release of its DDR4 RDIMM and LRDIMM chipsets, which include the DDR4 Registering Clock Driver (RCD) and the DDR4 Data Buffers (DB). The chipset fully supports Intel's next-generation Xeon Processor ES-2600 V3 product family.
Sign-up for Montage Announces the DDR4 RDIMM and LRDIMM Chipset for Intel's Next-Generation Xeon Processor ES-2600 V3 Product Family investment picks
Revenue growth of 36% to $1.63 billion Organic revenue growth for parts and services of 10.3% Net income growth of 24% to a record $104.7 million First quarter 2014 diluted EPS of $0.34 ($0.35, as adjusted) CHICAGO, April 29, 2014 (GLOBE NEWSWIRE) -- LKQ Corporation (Nasdaq:LKQ) today reported record revenue for the first quarter of 2014 of $1.63 billion, an increase of 35.9% as compared to $1.20 billion in the first quarter of 2013.
Sign-up for LKQ Corporation Announces Results for First Quarter 2014 investment picks
THE WOODLANDS, Texas, April 2, 2014 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (Nasdaq:LGIH) today announced 210 homes closed in March 2014, up from 116 homes closed in March 2013, representing year-over-year growth of 81.0%. In addition, the Company announced 485 homes closed for the first quarter of 2014.
Sign-up for LGI Homes, Inc. Reports March and First Quarter 2014 Home Closings investment picks
ST. PAUL, Minn., April 3, 2014 (GLOBE NEWSWIRE) -- Aetrium Incorporated (Nasdaq:ATRM) ("Aetrium" or the "Company") announced today that it has acquired substantially all of the assets of KBS Building Systems, Inc. and certain of its affiliated entities.
Sign-up for Aetrium Acquires KBS Building Systems investment picks
Vitaros ® National Phase Approval Process in Europe Completed SAN DIEGO, April 24, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI) , a pharmaceutical company focusing on the development and commercialization of novel therapeutics for men's and women's health, today announced that the Spanish Agency for Medicines and Health Products (AEMPS) has granted national phase approval to Vitaros ® , Apricus' novel topical on-demand treatment for erectile dysfunction ("ED"). With the approval in Spain, the Company has now received a total of ten national phase approvals for Vitaros ® , including Luxembourg, Belgium, France, Germany, Ireland, Italy, the Netherlands, Sweden and the United Kingdom (the "U.K.") following its broad approval by European health authorities in June 2013.
Sign-up for Apricus Biosciences Announces National Phase Approval for Vitaros(R) in Spain investment picks
BROOMFIELD, Colo., April 15, 2014 (GLOBE NEWSWIRE) -- Noodles & Company (Nasdaq:NDLS) today announced that it will host a conference call to discuss its first quarter 2014 financial results on Tuesday, April 29, 2014 at 4:30 PM Eastern Time.
Sign-up for Noodles & Company to Announce First Quarter 2014 Results on April 29, 2014 investment picks
NEW YORK, April 17, 2014 (GLOBE NEWSWIRE) -- NASDAQ OMX (Nasdaq:NDAQ) , the world's leading provider of market technology, was recently selected for 'Best Sell-Side Market Surveillance Product' by Waters Technology's Sell-Side Technology Awards.
Sign-up for NASDAQ OMX's SMARTS Wins Best Sell-Side Surveillance Product investment picks
AUSTIN, Texas, April 2, 2014 (GLOBE NEWSWIRE) -- LDR Holding Corporation (Nasdaq:LDRH) ("LDR" or the "Company"), a global medical device company focused on designing and commercializing novel and proprietary spinal surgical technologies, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to a proposed follow-on public offering of its common stock.
Sign-up for LDR Files Registration Statement for Follow-on Offering investment picks
SACRAMENTO, Calif., April 3, 2014 (GLOBE NEWSWIRE) -- Pacific Ethanol, Inc. (Nasdaq:PEIX) , the leading producer and marketer of low-carbon renewable fuels in the Western United States, announced it has priced an underwritten offering of 1,750,000 shares of its common stock at a price to the public of $16.00 per share, for gross offering proceeds of $28.0 million.
Sign-up for Pacific Ethanol, Inc. Prices $28 Million Offering of Common Stock investment picks
SAN DIEGO, April 3, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI) , a pharmaceutical company focusing on the development and commercialization of novel therapeutics for men's and women's health, today announced that the Ministry of Health of Luxembourg has granted national phase approval to Vitaros ® , Apricus' novel topical on-demand treatment for erectile dysfunction ("ED"). The Company has now received a total of nine national phase approvals for Vitaros ® , including Luxembourg, Belgium, France, Germany, Ireland, Italy, the Netherlands, Sweden and the United Kingdom ("UK") following its broad approval by European health authorities in June 2013.
Sign-up for Apricus Biosciences Announces National Phase Approval for Vitaros(R) in Luxembourg investment picks
HAMPTON, N.J., April 3, 2014 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that data from preclinical studies evaluating the anti-tumor activity of the antibody-drug conjugate (ADC) CDX-014 will be presented at the American Association of Cancer Research (AACR) Annual Meeting 2014 in San Diego, California, April 5-9.
Sign-up for Celldex Therapeutics to Present Antibody-Drug Conjugate CDX-014 Preclinical Proof of Concept Data at AACR 2014 investment picks
LOS ANGELES, April 3, 2014 (GLOBE NEWSWIRE) -- Global Eagle Entertainment (Nasdaq:ENT) today announced a new partnership with the world's fastest growing, cross platform digital newsstand, Magzter, to provide a catalogue of thousands of regional and international digital magazines for inflight entertainment.
Sign-up for Global Eagle Entertainment Partners With Magzter to Enable Passengers to Read Digital Magazines on Airlines investment picks
ST. LOUIS and MILWAUKEE, April 3, 2014 (GLOBE NEWSWIRE) -- Quinpario Acquisition Corp.
Sign-up for Quinpario Acquisition Corp. and Jason Incorporated Receive U.S. Antitrust Clearance in Regard to Pending Acquisition investment picks
SALT LAKE CITY, April 4, 2014 (GLOBE NEWSWIRE) -- American Sands Energy Corp.
Sign-up for American Sands Energy Corp. Completes Pilot Plant Acquisition investment picks
PORT WASHINGTON, N.Y., April 3, 2014 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET) , a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals Inc., its finished dosage form generics subsidiary, is launching the 10/12.5mg, 20/12.5mg and 20/25mg strengths of Benazepril/HCTZ, the authorized generic of Validus' Lotensin HCT ® .
Sign-up for ACETO Subsidiary, Rising Pharmaceuticals, Launches the Authorized Generic of Validus' Lotensin HCT(R) investment picks
NEWARK, Calif., April 17, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has completed enrollment in the Company's Phase I/II clinical trial in spinal cord injury.
Sign-up for StemCells, Inc. Completes Enrollment in Spinal Cord Injury Trial investment picks
MERRIMACK, N.H., April 7, 2014 (GLOBE NEWSWIRE) -- GT Advanced Technologies (Nasdaq:GTAT) today announced that it has received $58.6 million in orders this quarter for high temperature refractory metal furnaces that are used for a variety of industrial purposes.
Sign-up for GT Advanced Technologies Announces $58.6 Million Specialty Furnace Orders investment picks
AKRON, Ohio , April 21, 2014 /PRNewswire/ -- FirstEnergy Nuclear Operating Company (FENOC), a subsidiary of FirstEnergy Corp.
Sign-up for Beaver Valley Unit 2 Begins Refueling and Maintenance Outage investment picks
CHICAGO, April 24, 2014 (GLOBE NEWSWIRE) -- R.
Sign-up for RR Donnelley Awarded $175 Million Multi-Year Agreement by F+W Media, Inc. investment picks
PARIS, April 7, 2014 (GLOBE NEWSWIRE) -- Sanofi (EURONEXT: SAN and NYSE: SNY) and its subsidiary Genzyme announced today that following constructive discussions with the U.S. Food and Drug Administration (FDA) the company plans to resubmit in the second quarter its supplemental Biologics License Application (sBLA) seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis.
Sign-up for Sanofi: Genzyme to Resubmit Lemtrada Application for FDA Review investment picks
HONG KONG, April 7, 2014 (GLOBE NEWSWIRE) -- Willis Group Holdings (NYSE:WSH) , the global risk advisor, insurance and reinsurance broker, has announced the recruitment of Greg Solomon to the International division of its reinsurance business, Willis Re.
Sign-up for Willis Re Hires Greg Solomon to Capitalize on Rapid Growth in APMETA Life & Health Sector investment picks
KANSAS CITY, Mo., April 7, 2014 (GLOBE NEWSWIRE) -- Cerner (Nasdaq:CERN) announced today it will release its first quarter 2014 earnings results after the market closes on April 24.
Sign-up for Cerner to Release First Quarter 2014 Earnings Results April 24 investment picks
MILPITAS, Calif., April 7, 2014 (GLOBE NEWSWIRE) -- Intersil Corporation (Nasdaq:ISIL) , a leading provider of innovative power management and precision analog solutions, today announced the appointment of Diwakar Vishakhadatta as vice president of product development.
Sign-up for Intersil Announces Appointment of Diwakar Vishakhadatta as Vice President of Product Development investment picks
NORFOLK, Va., April 9, 2014 (GLOBE NEWSWIRE) -- Portfolio Recovery Associates, Inc. (Nasdaq:PRAA) , a financial and business services company operating in the U.S., Canada and the U.K., today announced that Darby Schoenfeld has been named director of investor relations.
Sign-up for PRA Names Investor Relations Director investment picks
http://media.marketwire.com/attachments/201210/94338_HZ-LOGO-TAG-RGB-300x100.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1108687&ProfileId=051205&sourceType=1 REDWOOD CITY, CA --
Sign-up for Rocket Fuel Publishes 11 Best Practices for Programmatic Advertising investment picks
PHILADELPHIA , April 23, 2014 /PRNewswire/ -- Crown Holdings, Inc. (NYSE: CCK) , a global leader in consumer packaging, today announced that it has completed its acquisition of Mivisa Envases, SAU, a leading Spanish manufacturer of two- and three-piece food cans and ends, from certain investment funds managed by affiliates of The Blackstone Group L.P., N+1 Mercapital and management.
Sign-up for Crown Holdings Completes Mivisa Acquisition investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: FireEye Awarded 5-Star Rating in CRN's 2014 Partner Program Guide to Crown Holdings Completes Mivisa Acquisition
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry